Medtide (FRA:FQ2) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:FQ2 Medtide Inc FRA:FQ2
31 GF Score
Price €2.18
View Full Analysis

What is Medtide FFO?

FFO (Funds from operations) only applies to REITs.

FRA:FQ2
31GF Score
Medtide Inc FRA:FQ2
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtide Business Description

Other Exchanges 03880:Hong Kong
Address No. 69, 12 Street, Qiantang District, Zhejiang, Hangzhou, CHN
Medtide Inc offers full-cycle services ranging from early-stage discovery, preclinical research and clinical development to commercial-stage production. It mainly provide (i) CRO services, namely peptide NCE discovery synthesis; and (ii) CDMO services, namely peptide CMC development and commercial manufacturing. Its services focus on providing customers with APIs rather than drug products. Geographically, the company generates majority of its revenue from USA.
31GF Score

Get the complete analysis for FRA:FQ2

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.18
Price